Partial laryngectomy in glottic cancer: complications and oncological results  by Graciano, Agnaldo José et al.
Braz J Otorhinolaryngol. 2016;82(3):275--280
www.bjorl.org
Brazilian Journal of
OTORHINOLARYNGOLOGY
ORIGINAL ARTICLE
Partial  laryngectomy  in  glottic  cancer:  complications
and oncological  results
Agnaldo José Gracianoa,∗, Marina Sonaglib, Ana Gabriela Clemente da Silvab,
Carlos  Augusto Fischera, Carlos Takahiro Chonec
a Department  of  Surgery,  Division  of  Otolaryngology  and  Head  and  Neck  Surgery,  Hospital  São  José,  Joinville,  SC,  Brazil
b Department  of  Surgery,  Hospital  São  José,  Joinville,  SC,  Brazil
c Department  of  Otolaryngology  and  Head  and  Neck  Surgery,  Universidade  Estadual  de  Campinas  (UNICAMP),  Campinas,  SP,  Brazil
Received 7  November  2014;  accepted  5  May  2015
Available  online  19  October  2015
KEYWORDS
Carcinoma;
Larynx;
Laryngectomy;
Radiotherapy
Abstract
Introduction:  Most  patients  with  laryngeal  carcinoma  present  tumors  in  the  glottis  that  can  be
treated by  different  treatment  modalities.  Some  authors  consider  open  partial  laryngectomy
as obsolete,  while  others  still  deem  this  as  a  viable  and  cost-efﬁcient  option.
Objectives:  To  compare  the  oncological  and  functional  results  of  a  series  of  patients  undergoing
partial laryngectomy  vs.  external  radiotherapy  for  the  treatment  of  glottic  cancer.
Methods:  Historical  cohort  study  with  a  series  of  glottic  carcinoma  patients  undergoing  partial
laryngectomy  or  external  radiotherapy  during  a  period  of  ten  years.
Results:  Sixty-two  patients  with  glottic  carcinoma  were  included.  Group  A  comprised  those
submitted to  partial  laryngectomy  (n  =  30),  and  Group  B,  those  who  underwent  radiotherapy
(n =  32).  They  were  homogeneous  in  the  comparison  of  mean  age,  56.4  vs.  60.4  years  (p  =  0.12)
and distribution  in  pathological  stage  (p  =  0.91).  With  regard  to  oncological  outcome,  there  were
no differences  in  distant  metastasis  rates,  or  second  primary  tumor  between  groups  (p  =  1.0),  as
well as  in  disease-free  time,  laryngeal  rescue-free  time,  and  overall  ﬁve-year  survival.  Severe
complication  rates  were  also  similar  between  groups.
Conclusion:  Open  partial  laryngectomy  had  complication  rates  and  oncological  results  similar
to those  of  radiotherapy  for  patients  with  glottic  carcinomas  and  should  still  be  considered
among the  main  available  therapeutic  options.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published  by
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Laringectomia  parcial  no  câncer  glótico:  complicac¸ões  e  resultados  oncológicos
Resumo
Introduc¸ão:  A  maioria  dos  pacientes  com  carcinoma  de  laringe  apresentam  tumores  na  região
glótica suscetíveis  a  diferentes  modalidades  de  tratamento.  Alguns  autores  consideram  a
laringectomia  parcial  aberta  em  desuso  enquanto  outros  ainda  a  indicam  como  uma  opc¸ão
viável e  custo  eﬁciente.
Objetivos:  Comparar  os  resultados  oncológicos  e  funcionais  de  uma  série  de  pacientes  submeti-
dos à  laringectomia  parcial  versus  radioterapia  externa  para  o  tratamento  do  câncer  glótico.
Método: Estudo  tipo  coorte  histórica  com  uma  série  de  pacientes  com  carcinoma  glótico  sub-
metidos à  laringectomia  parcial  ou  radioterapia  externa  em  período  de  10  anos.
Resultados:  Foram  incluídos  62  pacientes  com  carcinoma  glótico  distribuídos  em  Grupo  A:  sub-
metido à  laringectomia  parcial  (n  =  30)  e  Grupo  B  submetido  a  radioterapia  (n  =  32)  que
se mostraram  homogêneos  na  comparac¸ão  de  média  de  idade  de  56,4  vs.  60,4  (p  =  0,12)  e
distribuic¸ão em  estadios  patológicos  (p  =  0,91).  Com  relac¸ão  ao  desfecho  oncológico,  não  foram
observadas  diferenc¸as  nas  taxas  de  metástase  à  distancia,  ou  segundo  primário  entre  os  grupos
(p =  1,0)  assim  como  no  tempo  livre  de  doenc¸a,  tempo  livre  de  resgate  laríngeo  e  sobrevida
geral em  5  anos.  As  taxas  de  complicac¸ões  severas  também  foram  semelhantes  entre  os  grupos.
Conclusão:  A  laringectomia  parcial  aberta  apresentou  taxas  de  complicac¸ões  e  resultados
oncológicos  semelhante  àqueles  do  tratamento  radioterápico  para  pacientes  com  carcinomas
glóticos  e  ainda  deve  ser  considera  entre  as  principais  opc¸ões  terapêuticas  disponíveis.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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on  days  1--4  and  22--25  was  performed  concomitantly  with
radiation  for  patients  with  T2  or  T3  tumors  (thus  excludingntroduction
aryngeal  carcinoma  varies  in  incidence  throughout  differ-
nt  geographical  regions,  being  more  common  in  Southern
urope  (10.9/100,000),  Eastern  Europe  (9.2/100,000),  and
outh  America  (7.2/100,000).  This  cancer  is  more  frequent
n  males  and  corresponds  to  2.5%  of  all  tumors  in  men,
epresenting  the  sixth  most  common  malignancy  in  men
n  Brazil.1 Most  patients  with  laryngeal  carcinoma  present
heir  tumor  in  the  glottic  region,  and  55--75%  are  diag-
osed  with  early  cancers,  with  a  favorable  prognosis.2--5
herefore,  in  these  cases  whenever  possible  the  therapy  for
aryngeal  cancer  should  aim  for  a  high  rate  of  local  con-
rol  associated  with  preservation  of  function.  Such  results
an  be  achieved  by  different  approaches,  including  exter-
al  beam  radiotherapy,  transoral  laser  microsurgery,  partial
pen  laryngectomy  and,  more  recently,  robotic  transoral
urgery.  Each  of  these  options  has  speciﬁc  advantages  and
imitations,  such  as  tumor  extension,  need  for  functional
econstruction,  technical  skill,  and  adequate  resources.6,7
Currently,  a  predominance  of  radiotherapy  and  transoral
aser  microsurgery  appear  to  be  the  treatment  modalities
ost  commonly  used,  particularly  for  early  glottic  carcino-
as,  with  open  partial  laryngectomy  considered  by  some
uthors  to  be  falling  into  disfavor.8 However,  others  have
oted  that  open  surgery  can  guarantee  an  adequate  oncolo-
ical  control,  associated  with  a  more  accurate  pathological
taging  for  the  correct  indication  of  adjuvant  therapy  and
isk  stratiﬁcation  of  these  patients.9,10 Although  surgery  and
adiation  therapy  have  coexisted  as  a  treatment  for  can-
er  of  the  larynx  since  the  early  20th  century,  there  are
till  conﬂicting  results  when  these  two  therapeutic  modal-
ties  are  compared.  The  aim  of  this  study  was  to  evaluate
he  oncological  and  functional  results  of  a  series  of  patients
p
tndergoing  open  partial  laryngectomy  vs.  external  radiothe-
apy  for  the  treatment  of  glottic  cancer  of  larynx.
ethods
his  was  a  longitudinal  historical  cohort  study  approved
y  the  local  Research  Ethics  Committee  under  No.
0538013.2.0000.5362  and  based  on  data  collection  of  medi-
al  records  from  patients  with  squamous  cell  carcinoma  in  a
lottal  laryngeal  site,  conﬁrmed  by  the  pathology  service
nd  submitted  to  partial  laryngectomy  or  external  beam
adiation  therapy  at  a  tertiary  center  from  2002  to  2012.
atients  with  selected  T1/T2  and  T3  early  glottic  carcinoma
imited  to  the  glottis  without  massive  extension  to  the  supra-
lottis,  infraglottis  or  to  the  paraglottic  space,  and  who
ere  suitable  for  treatment  with  organ  preservation,  were
onsidered  for  inclusion  criteria  in  the  study.  Patients  with
ulky  T3  glottic  carcinoma  not  suitable  for  conservative  sur-
ical  treatment  and  patients  with  advanced  T4  carcinoma,
s  well  as  patients  with  minimal  clinical  follow-up  (less  than
4  months)  were  excluded  from  the  study.
All  patients  were  informed  about  treatment  options  by  a
ultidisciplinary  team  involving  surgeons,  radiation  oncolo-
ists,  and  medical  oncologists,  and  after  counseling  under-
ent  partial  laryngectomy  or  radiation  therapy  with  a  total
ose  of  70  Gy  (fractionated  at  2  Gy/day,  ﬁve  days  per  week)
s  initial  treatment,  depending  on  the  patient’s  preference.
hemotherapy  with  cisplatin  20  mg/m2/day  in  combination
ith  5-ﬂuorouacil  1000  mg/m2/day  by  intravenous  infusionatients  with  T1  glottic  carcinoma)  according  to  institu-
ional  protocol.  Adjuvant  radiotherapy  after  surgery  was
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Table  1  Distribution  according  clinical  staging.
Staging  Radiotherapy  Open  surgery  p
EC  1  17  (53.10%)  13  (43.33%)
EC 2  9  (28.10%)  7  (23.33%)
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indicated  for  patients  who  presented  narrow-compromised
surgical  margins,  vascular/perineural  invasion,  and/or
regional  metastasis.  After  the  selection  of  patients,  an
evaluation  of  homogeneity  between  the  groups  was  con-
ducted,  and  the  comparability  of  samples  was  determined.
The  epidemiological  characteristics,  initial  treatment  type,
need  for  a  temporary  (during  the  treatment  period)  or
permanent  (patients  who  were  unable  to  maintain  venti-
lation  without  tracheostomy  after  the  end  of  treatment)
tracheostomy,  use  of  enteral  nutrition  via  nasogastric  tube
or  gastrostomy,  complications  during  treatment  (aspiration
pneumonia,  blood  transfusion,  salivary  ﬁstula),  and  need
for  adjuvant  treatment  (radiotherapy  and/or  chemother-
apy)  were  evaluated.  An  evaluation  of  oncological  results  for
three-year  disease-free  time,  local-regional  recurrence-free
time,  and  overall  ﬁve-year  survival  was  conducted.
Statistics
The  results  of  quantitative  variables  were  described  as
mean,  median,  minimum  and  maximum  values,  and  standard
deviations.  Qualitative  variables  were  expressed  as  frequen-
cies  and  percentages.  To  compare  the  groups  deﬁned  by  the
initial  treatment  (radiation  therapy  or  surgery)  compared  to
mean  age,  Student’s  t-test  was  used  for  independent  sam-
ples.  Regarding  qualitative  variables,  either  Fisher’s  exact
test  or  the  chi-squared  test  was  employed  for  this  com-
parison.  The  comparison  between  groups  with  respect  to
disease-free  time,  laryngeal  rescue-free  time,  and  survival
time  was  carried  out  using  the  Log-rank  test.  Kaplan--Meier
curves  were  presented  in  order  to  describe  the  evolution  of
the  cases  in  both  groups  compared  to  the  times  of  interest.
p-Values  <  0.05  were  considered  as  statistically  signiﬁcant.
ResultsDuring  ten  years,  199  patients  with  laryngeal  carcinoma
aged  between  30  and  84  years,  92.5%  male,  were  evaluated.
The  most  common  site  of  laryngeal  cancer  was  the  glottis
I
m
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Table  2  Complications  and  functional  results.
Laryngectomy  
Temporary  tracheostomy  30  (100%)  
Permanent tracheostomy  7  (23.7%)  
Blood transfusion  2  (6.9%)  
Aspiration pneumonia  3  (10%)  
Salivary ﬁstula  4  (13.3%)  
Enteral diet  27  (90%)  
Gastrostomy  2  (6.6%)  Figure  1  Relapse-free  time/months.
n  99  patients  (49.25%),  followed  by  the  supraglottic  area  in
2  cases  (26.13%),  while  another  49  patients  (24.62%)  had
arge  lesions  classiﬁed  as  transglottic  tumors.
Among  the  199  patients  with  laryngeal  carcinoma,  62
atients  with  glottic  carcinoma  were  included  and  divided
nto  two  groups  according  to  the  initial  proposed  treatment:
roup  A  underwent  partial  laryngectomy  (n  =  30)  and  Group
 underwent  radiotherapy,  with  or  without  chemotherapy
n  =  32).  Supracricoid  laryngectomy  was  performed  on  18
atients  (two  T1b,  six  T2,  ten  T3),  while  frontolateral  laryn-
ectomy  was  used  in  12  patients  (11  T1a  and  one  T2).  Both
roups  were  homogeneous  when  comparing  mean  age  (57.5
s.  59.5  years  for  patients  undergoing  surgery  or  radiothe-
apy,  respectively).  The  same  was  observed  for  distribution
n  different  clinical  staging  for  the  two  groups  (Table  1).
valuations  of  complications  during  treatment  and  func-
ional  results  are  presented  in  Table  2. With  regard  to
ncological  outcome,  no  differences  were  observed  in  dis-
ant  metastasis  occurrence  rate  or  in  second  primary  tumor
etween  groups,  as  well  as  in  disease-free  time,  laryngeal
escue-free  time,  and  overall  ﬁve-year  survival,  as  shown  in
igs.  1--3.
iscussiont  is  currently  accepted  that  radiotherapy,  transoral  laser
icrosurgery,  and  open  partial  laryngectomy  can  provide
igh  local  control  rates  for  patients  with  early  glottic  carci-
oma  of  larynx  coupled  with  functional  conservation  of  the
Radiotherapy  p-Value
15  (46.8%)  <0.001
8  (25%)  1
4  (12.5%)  0.45
3  (9.35%)  1
0  0.03
13  (40.6%)  <0.001
1  (3.2%)  0.65
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Figure  2  Larynx  rescue-free  time.
rgan.  However,  there  appears  to  be  no  high-level  evidence
egarding  the  best  treatment  option  for  these  patients,
ecause  of  the  lack  of  randomized  studies  comparing
hese  different  treatment  options.11 Conservative  surgery
as  been  one  of  the  mainstays  of  treatment  of  laryngeal
ancer  since  the  ﬁrst  successful  resection  via  laryngoﬁssure
redited  to  Sands  in  1863,12 and  later  followed  by  the
escription  of  a  hemilaryngectomy  performed  by  Billroth  in
875.13 In  parallel  to  the  development  of  new  techniques
or  partial  laryngectomy,  the  evolution  of  radiation  therapy
esulted  in  an  effective  option  for  conservative  treatment
or  laryngeal  carcinomas.14 Since  then,  some  studies  have
ried  to  assess  the  oncological  outcomes  of  radiotherapy  and
onservative  surgery  for  glottic  carcinomas,  but  conﬂicting
esults  are  often  described,  as  those  observed  by  Bron
t  al.15 and  Zohar  et  al.,16 who  found  higher  local  control
ates  compared  to  those  of  open  surgery,  while  Rucci  et  al.17
uggested  that  the  local-regional  control  with  radiotherapy
ould  be  more  efﬁcient,  particularly  for  patients  with  T1a
nd  T1b  glottic  carcinomas.
However,  Pontes  et  al.18 followed  43  patients  with  T1a
nd  T1b  laryngeal  carcinoma  submitted  to  an  initial  treat-
ent  with  radiotherapy  and  observed  a  high  recurrence
ate  in  30.2%  of  patients  after  a  mean  follow-up  time  of
9.5  months.  In  the  present  series,  it  was  observed  that
Death Survival
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he  overall  three-year  disease-free  rates  were  similar  both
or  patients  undergoing  partial  laryngectomy  (80.8%)  and  for
hose  undergoing  radiotherapy  (76.9%).  Although  there  are
ew  studies  that  directly  compared  the  oncological  results  of
artial  laryngectomy  vs.  radiotherapy  for  selected  early  and
3  glottic  carcinomas  in  the  same  institution,  in  1984  Kaplan
t  al.19 indicated  that  patients  with  early  glottic  carcinomas
ad  similar  oncological  outcomes  when  treated  with  radio-
herapy  or  surgery.  However,  it  was  observed  that  surgery
as  superior  to  radiotherapy  in  patients  with  reduced  or
xed  vocal  fold  mobility  (patients  selected:  T2  and  T3);
hus,  it  was  suggested  that  open  laryngectomy  should  be  the
rst  line  of  treatment  for  these  patients.  These  results  were
orroborated  in  a  recent  evidence-based  review  by  Hartl
t  al.20;  these  authors  concluded  that  patients  with  T2  glot-
ic  carcinoma  can  achieve  initial  local  control  rates  between
4%  and  95%,  which  are  comparable  to  rates  after  radio-
herapy,  open  partial  surgery,  or  transoral  laser  resection.
owever,  they  emphasized  that  patients  with  T2  glottic  car-
inoma  presenting  reduced  mobility  or  deep  extension  to
araglottic  space  or  ventricle  represented  a  subgroup  with
ower  local  control  rates,  when  subjected  to  radiation  or
aser  transoral  surgery.  Succo  et  al.21 also  suggested  that
pen  partial  surgery  results  in  higher  local  control  and  long-
erm  laryngeal  preservation  rates  in  patients  with  glottic
arcinoma,  showing  decreased  or  ﬁxed  vocal  cord  mobil-
ty  compared  to  those  treated  with  transoral  laser  surgery,
nd  considered  that  this  was  due  to  the  fact  that  16.8%  of
atients  clinically  staged  as  cT2  were  classiﬁed  as  pT3  with
athological  staging,  and  that  this  group  would  be  particu-
arly  favored  by  partial  laryngectomy.
In  general,  there  is  evidence  suggesting  that  patients
ith  glottic  cancer  show  similar  ﬁve-year  survival  rates  after
adiotherapy  or  open  partial  laryngectomy,  ranging  from  70%
o  88%  for  patients  with  T1  carcinoma  and  between  64%  and
8%  for  T2  tumors.4 The  same  can  be  observed  in  the  present
tudy,  with  overall  ﬁve-year  survival  rates  of  77.4%  and  72.9%
fter  radiotherapy  and  surgery,  respectively.
Considering  the  possibility  of  similar  oncological  results,
ome  authors  suggest  that  partial  laryngectomy  should  be
onsidered  as  the  ﬁrst  therapeutic  choice  for  glottic  tumors,
llowing  a  precise  pathological  staging  of  the  disease;  radio-
herapy  would  be  reserved  for  adjuvant  therapy,  or  for  a
econd  primary  carcinoma.22 However,  radiotherapy  is  the
rimary  form  of  initial  treatment  for  glottic  carcinoma  in
ost  centers  and  reaches  rates  of  84.4%  of  cases  in  Canada
nd  63.2%  of  patients  in  the  United  States.23 One  advantage
f  radiotherapy  is  the  possibility  of  avoiding  a  temporary
r  permanent  tracheostomy  usually  associated  with  con-
ervative  laryngectomy.  However,  the  authors  noted  that,
espite  the  fact  that  temporary  tracheostomies  have  been
ore  frequent  in  patients  undergoing  partial  laryngectomy,
eﬁnitive  tracheostomy  rates  (patients  who  could  not  be
ecannulated  after  initial  treatment)  were  28.1%  and  23.3%
fter  radiotherapy  and  open  partial  laryngectomy,  respec-
ively.  Therefore,  considering  permanent  tracheostomy  as
he  main  negative  functional  consequence  in  the  treatment
f  patients  with  laryngeal  carcinoma,24,25 the  present  study
id  not  observe  a signiﬁcant  difference  between  these  ther-
peutic  modalities  regarding  this  issue.
Another  important  aspect  of  the  functional  preservation
f  the  larynx  is  the  protection  fostered  by  lower  airways,
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allowing  continuation  of  a  non-restricted  oral  diet.  While  the
need  for  temporary  enteral  nutrition  was  signiﬁcantly  higher
in  patients  undergoing  surgery,  it  should  be  noted  that  40.6%
of  patients  undergoing  radiotherapy  also  required  enteral
nutrition  during  treatment,  and  similar  rates  of  dietary  need
for  temporary  gastrostomy  were  observed,  both  in  patients
undergoing  radiation  therapy  (3.2%)  and  open  partial  laryn-
gectomy  (6.7%).  Dysphagia  after  partial  laryngectomy  is  due
to  local  changes,  caused  by  resection  of  structures  and  also
by  changes  in  the  mechanism  of  laryngeal  elevation,  while
radiation  causes  damage  to  the  mucosa  and  pharyngolaryn-
geal  muscle  tissues  that  is  directly  related  to  the  therapeutic
dose  used.
Debelleix  et  al.26 reviewed  the  literature  and  concluded
that,  to  reduce  the  laryngeal  edema,  it  would  be  appropri-
ate  to  limit  the  radiation  dose  incident  to  non-tumor  areas
of  the  larynx  to  about  40--45  Gy;  but  today  most  patients
receive  70  Gy  in  conventional  radiotherapy.  Francis  et  al.
evaluated  the  relationship  between  the  therapeutic  modal-
ity  and  the  potential  of  long-term  dysphagia  in  patients  with
head  and  neck  cancer,  concluding  that  patients  undergoing
radiotherapy  and  chemotherapy  are  2.5  times  more  prone
to  undergo  dysphagia  compared  to  patients  undergoing  sur-
gical  treatment  alone.27 Other  drawbacks  in  the  quality  of
life  for  patients  with  laryngeal  cancer  are  also  reported,
for  instance,  worsening  in  voice  quality  and  a  predisposi-
tion  to  respiratory  infections  (aspiration  pneumonia)  due  to
weakness  in  swallowing.  Traditionally,  it  has  been  consid-
ered  that  surgery,  either  open  or  endoscopic,  is  responsible
for  the  higher  incidence  of  these  undesirable  effects  when
compared  to  radiation  therapy.  This  study  demonstrated
that  the  incidence  of  aspiration  pneumonia  was  comparable
after  radiotherapy  (9.35%)  and  open  partial  laryngectomy
(10%).  Some  studies  have  also  shown  that  partial  laryngec-
tomy  promotes  better  results  concerning  dental  problems,
dry  mouth,  and  swallowing  in  general.4,8
Although  the  literature  suggests  that  oncological  and
functional  results  can  be  similar  when  comparing  open  par-
tial  laryngectomy  vs.  radiotherapy  for  patients  with  glottic
cancer,  the  authors  have  noted  a  decline  in  the  use  of  open
surgery  in  recent  decades  in  favor  of  less  invasive  treatment
modalities,  such  as  radiation  or  transoral  laser  resection.
However,  it  is  important  to  emphasize  that  partial  laryn-
gectomy  remains  an  oncologically  and  functionally  effective
option,  especially  for  patients  with  glottic  carcinomas  with
a  decrease  or  ﬁxation  of  vocal  fold  mobility,  or  in  situations
such  as  unavailability  of  laser  technology  or  even  in  radio-
therapy  services  with  a  long  waiting  time  for  treatment.
Conclusion
Open  partial  laryngectomy  presented  disease-free  time
and  overall  survival  outcomes  similar  to  those  obtained
with  radiotherapy  for  selected  patients  with  early  glot-
tic  and  T3  carcinomas,  also  demonstrating  similar  rates  of
severe  laryngeal  dysfunction  with  need  of  permanent  tra-
cheostomy.  Therefore,  this  procedure  must  be  maintained
among  the  main  therapeutic  modalities  available  for  such
cases,  and  the  treatment  selection  should  consider  the  avail-
ability  of  local  resources,  waiting  time  for  each  treatment
modality,  and  personal  preferences.
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